Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
Longitudinal association between depressive symptoms and walking impairment in people with relapsing-remitting multiple sclerosis.
DSM-III disorders from age 11 to age 15 years.
What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review.
Efficacy and safety of FTY720 in patients with relapsing multiple sclerosis
Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine.
Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System.
Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis.
Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study.
Diagnosis and differential diagnosis of multiple sclerosis.
Notch Signaling and T-Helper Cells in EAE/MS.
Determinants of disability using count-based approaches to icf-based definition of neurological disability.
IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls.
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Multiple sclerosis: Study in MS reveals impairments in 'theory of mind'
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Residential Distance to High-voltage Power Lines and Risk of Neurodegenerative Diseases: a Danish Population-based Case-Control Study.
Pages
« first
‹ previous
…
314
315
316
317
318
319
320
321
322
…
next ›
last »